Keriton reported raising $1.16 Million in an initial SEC Form D filing, from an offering of $1.16 Million
Round Type
Seed
Quick answer
Keriton raised $1.16 Million in a Seed round, dated September 27, 2022. Keriton is based in Philadelphia, Pennsylvania, United States.
- How much did Keriton raise?
- Keriton raised $1.16 Million in a Seed round on September 27, 2022.
- What does Keriton do?
- Keriton Kare (www.keriton.com) is the most advanced feeding management, lactation analytics and patient engagement platform for neonatal ICUs.
- Where is Keriton based and how big is it?
- Keriton is based in Philadelphia, Pennsylvania, United States.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as Keriton that raised within 45 days of this round, from Fundz verified event records.
- LUMINOPIA raised an undisclosed amount (Seed) on November 11, 2022.
- Curevo raised $22M on November 10, 2022.
- Avstera Therapeutics raised an undisclosed amount (Seed) on November 9, 2022.
- MBX Biosciences, Inc. raised $47M on November 7, 2022.
- Metabolon raised $10M on November 1, 2022.
- Statera Biopharma raised $577K (Seed) on November 1, 2022.
Who to call at Keriton, and when
A new round usually means Keriton is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Keriton raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Keriton, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Keriton. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Keriton raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Keriton raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.